We are live on ! Find out more
SCR

SIMCERE PHARMACEUTICAL GROUP, ADS
SCR

Delisted

SCR was delisted on the 23rd of December, 2013.

Back to rankings

20 hedge funds and large institutions have $20.1M invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

21% more capital invested

Capital invested by funds: $16.6M → $20.1M (+$3.43M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 21 → 20 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $389K

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
6
Reduced
4
Closed
3
Calls
–
Puts
$389K
Net Calls
-$389K
Net Calls Change
+$131K

Top Buyers

1
PRCM
Pine River Capital Management
Minnesota
+$1.67M
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$1.07M
3
WAM
Wolverine Asset Management
Illinois
+$960K
4
PCM
Pentwater Capital Management
Florida
+$185K
5
Renaissance Technologies
Renaissance Technologies
New York
+$112K

Top Sellers

1
Invesco
Invesco
Georgia
-$533K
2
Two Sigma Investments
Two Sigma Investments
New York
-$99K
3
U
UBS
Switzerland
-$9.99K
4
Ameriprise
Ameriprise
Minnesota
-$6.69K
5
Bank of America
Bank of America
North Carolina
-$5.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$5.67M – – –
PRCM
2
Pine River Capital Management
Minnesota
$4.07M +$1.67M +176,145 +69%
SGA
3
Siguler Guff Advisers
New York
$3.24M – – –
PCM
4
Pentwater Capital Management
Florida
$2.58M +$185K +19,536 +8%
COPPSERS
5
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.07M +$1.07M +113,323 New
WAM
6
Wolverine Asset Management
Illinois
$959K +$960K +101,409 New
EC
7
EJF Capital
Virginia
$463K – – –
HK
8
Horizon Kinetics
New York
$454K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$375K +$112K +11,800 +42%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$283K – – –
Baillie Gifford & Co
11
Baillie Gifford & Co
United Kingdom
$231K – – –
TD Asset Management
12
TD Asset Management
Ontario, Canada
$214K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$185K – – –
Deutsche Bank
14
Deutsche Bank
Germany
$150K +$86.2K +9,100 +134%
Barclays
15
Barclays
United Kingdom
$57K +$30K +3,166 +99%
Group One Trading
16
Group One Trading
Illinois
$17K +$1.89K +200 +13%
Bank of America
17
Bank of America
North Carolina
$14K -$5.73K -605 -29%
U
18
UBS
Switzerland
$12K -$9.99K -1,055 -46%
BFA
19
BlackRock Fund Advisors
California
$2K -$625 -66 -28%
Invesco
20
Invesco
Georgia
– -$533K -56,272 Closed
Two Sigma Investments
21
Two Sigma Investments
New York
– -$99K -10,398 Closed
Ameriprise
22
Ameriprise
Minnesota
– -$6.69K -706 -99%

SCR Hedge Fund Activity: Q3 2013 in Review

20 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q3 2013, worth a combined $20.1M — up 21% from $16.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SCR and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 6 added.

The largest buyer was Pine River Capital Management, adding an estimated $1.67M. The largest seller was Invesco, exiting entirely with an estimated $533K sold.

  • 20 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q3 2013, down from 21 in Q2 2013.
  • Funds reported $20.1M of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q3 2013, up 21% quarter-over-quarter.
  • 2 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q3 2013 and 3 closed out, a net change of -1 holder.
  • The largest SIMCERE PHARMACEUTICAL GROUP, ADS buyer in Q3 2013 was Pine River Capital Management, an estimated $1.67M added.
  • The largest SIMCERE PHARMACEUTICAL GROUP, ADS seller in Q3 2013 was Invesco, an estimated $533K sold.

Based on aggregated 13F filings for Q3 2013.